Home/MipSalus/Amanda Andresen

AA

Amanda Andresen

Chief Operating Officer

Therapeutic Areas

Metabolic Disorders Rare Diseases

MipSalus Pipeline

Drug	Indication	Phase
Phenylalanine-binding MIP	Hyperphenylalaninemia (HPA), including Phenylketonuria (PKU)	Pre-clinical

Leadership Team at MipSalus

Nicolas O. Krogh

Chief Executive Officer

Klaus Gregorius

Chief Scientific Officer

View full MipSalus profile